Literature DB >> 9797240

Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.

R Piccolomini1, G Catamo, G Di Bonaventura.   

Abstract

The susceptibilities of 87 periodontitis-associated strains of Actinobacillus actinomycetemcomitans to clarithromycin and erythromycin were determined by standard methodology recommended for Haemophilus influenzae. For clarithromycin the MIC at which 90% of the isolates were inhibited was </=2.0 microg/ml and the minimal bactericidal concentration at which 90% of the strains were killed was </=4.0 microg/ml, suggesting that it would be a candidate for therapeutic trials in patients with periodontitis.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9797240      PMCID： PMC105980     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  R L Mandell; L S Tripodi; E Savitt; J M Goodson; S S Socransky
Journal:  J Periodontol       Date:  1986-02       Impact factor: 6.993

2.  Laboratory and clinical comparison of preservation media and transport conditions for survival of Actinobacillus actinomycetemcomitans.

Authors:  R Piccolomini; G Catamo; G Di Bonaventura; C Picciani; M Paolantonio
Journal:  J Med Microbiol       Date:  1998-08       Impact factor: 2.472

3.  In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin.

Authors:  R Piccolomini; G Di Bonaventura; G Catamo; C Picciani; M Paolantonio
Journal:  Oral Microbiol Immunol       Date:  1997-12

4.  Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy.

Authors:  E J Goldstein; D M Citron; A E Vagvolgyi; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

5.  Adhesion of Actinobacillus actinomycetemcomitans to a human oral cell line.

Authors:  K P Mintz; P M Fives-Taylor
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

6.  Selective medium for isolation of Actinobacillus actinomycetemcomitans.

Authors:  J Slots
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

7.  A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells.

Authors:  F Scaglione; G Demartini; S Dugnani; F Fraschini
Journal:  Chemotherapy       Date:  1993 Nov-Dec       Impact factor: 2.544

8.  In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.

Authors:  R Pajukanta; S Asikainen; M Saarela; S Alaluusua; H Jousimies-Somer
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

9.  In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.

Authors:  Y Miyake; K Tsuruda; K Okuda; Y Iwamoto; H Suginaka
Journal:  J Periodontal Res       Date:  1995-07       Impact factor: 4.419

10.  Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers.

Authors:  F Kees; M Wellenhofer; H Grobecker
Journal:  Infection       Date:  1995 May-Jun       Impact factor: 3.553
View more
  6 in total

1.  Azithromycin enhances phagocytic killing of Aggregatibacter actinomycetemcomitans Y4 by human neutrophils.

Authors:  Pin-Chuang Lai; Mark R Schibler; John D Walters
Journal:  J Periodontol       Date:  2015-01       Impact factor: 6.993

2.  Clarithromycin accumulation by phagocytes and its effect on killing of Aggregatibacter actinomycetemcomitans.

Authors:  Irma Iskandar; John D Walters
Journal:  J Periodontol       Date:  2010-10-08       Impact factor: 6.993

3.  Clarithromycin transport by gingival fibroblasts and epithelial cells.

Authors:  C-H Chou; J D Walters
Journal:  J Dent Res       Date:  2008-08       Impact factor: 6.116

4.  Distribution of systemic clarithromycin to gingiva.

Authors:  Renita C Burrell; John D Walters
Journal:  J Periodontol       Date:  2008-09       Impact factor: 6.993

5.  Evaluating the effectiveness of clarithromycin as an adjunct to scaling and root planing: A randomized clinical trial.

Authors:  Jammula Suryaprasanna; Potini Lakshmi Radhika; Parupalli Karunakar; Koduganti Rekharani; Umrana Faizuddin; Mallela George Manojkumar; Suribabu Jammula
Journal:  J Indian Soc Periodontol       Date:  2018 Nov-Dec

6.  Impact of antibiotics on smell dysfunction.

Authors:  Jing-Jie Wang; Jonathan Chen; Richard L Doty
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-06-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.